Biktarvy, formally known as biktarvy, represents a potent single-tablet regimen for controlling HIV infection. This formula combines three key antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It works by blocking the virus's ability to replicate within the body, considerably lowering the viral burden. For many individu